Alpic Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.55 Cr
as on 16-11-2024
- Revenue -26.25%
(FY 2023)
- Profit -27.96%
(FY 2023)
- Ebitda -56.87%
(FY 2023)
- Net Worth 7.17%
(FY 2023)
- Total Assets 5.08%
(FY 2023)
About Alpic Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.55 Cr.
Uma Jaiswal, Harsh Jaiswal, Riya Jaiswal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PLC046614
- Company No.
046614
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Alpic Biotech Limited offer?
Alpic Biotech Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Antifungal Cream, Ointment & Powder, Clobetasol Propionate Cream, Antibiotic Syrup & Oral Suspension, Azithromycin Suspension Syrup, Allopathic Cough Syrup, Dextromethorphan Cough Syrup, Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Alpic Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsh Jaiswal  | Whole-Time Director | 10-Apr-2019 | Current |
| Uma Jaiswal | Whole-Time Director | 16-Aug-2005 | Current |
| Riya Jaiswal | Whole-Time Director | 15-Sep-2022 | Current |
| Pradeep Jaiswal | Whole-Time Director | 16-Aug-2005 | Current |
Financial Performance of Alpic Biotech.
Alpic Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.25% decrease. The company also saw a substantial fall in profitability, with a 27.96% decrease in profit. The company's net worth moved up by a moderate rise of 7.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpic Biotech?
In 2023, Alpic Biotech had a promoter holding of 99.97% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Abl Lifecare Private LimitedActive 18 years 8 months
Harsh Jaiswal and Pradeep Jaiswal are mutual person
- Glacus Healthcare LimitedActive 11 years 15 days
Harsh Jaiswal and Pradeep Jaiswal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Feb 2023 | ₹1.50 Cr | Open |
Others Creation Date: 19 Mar 2022 | ₹2.23 Cr | Open |
Others Creation Date: 19 Mar 2022 | ₹1.10 M | Open |
How Many Employees Work at Alpic Biotech?
Unlock and access historical data on people associated with Alpic Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpic Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpic Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
